810 related articles for article (PubMed ID: 16316848)
21. Leydig cell hyperplasia and Leydig cell tumour in postmenopausal women: report of two cases.
Hofland M; Cosyns S; De Sutter P; Bourgain C; Velkeniers B
Gynecol Endocrinol; 2013 Mar; 29(3):213-5. PubMed ID: 22835278
[TBL] [Abstract][Full Text] [Related]
22. An ovarian Leydig cell tumor of ultrasound negative in a postmenopausal woman with hirsutism and hyperandrogenism: A case report.
Chen M; Zhou W; Zhang Z; Zou Y; Li C
Medicine (Baltimore); 2018 Mar; 97(10):e0093. PubMed ID: 29517680
[TBL] [Abstract][Full Text] [Related]
23. Ovarian Leydig Cell Tumor Associated with Recurrent Torsion and Virilization in an Adolescent Patient.
Roth L; Smith AK; Buza N; Coons B; Stitelman D; Vash-Margita A
J Pediatr Adolesc Gynecol; 2024 Apr; 37(2):217-219. PubMed ID: 38110028
[TBL] [Abstract][Full Text] [Related]
24. Occult virilizing ovarian tumours in postmenopausal women: problems in evaluation with reference to a case.
Loh KC; Lo JC; Zaloudek CJ; Fitzgerald PA
Ann Acad Med Singap; 1998 Sep; 27(5):712-6. PubMed ID: 9919347
[TBL] [Abstract][Full Text] [Related]
25. Malignant ovarian Sertoli-Leydig cell tumor localized with selective ovarian vein sampling.
Dunne C; Havelock JC
J Minim Invasive Gynecol; 2012; 19(6):789-93. PubMed ID: 23084689
[TBL] [Abstract][Full Text] [Related]
26. A steroid-cell tumor of the ovary resulting in massive androgen excess early in the gonadol steroidogenic pathway.
Stephens JW; Fielding A; Verdaguer R; Freites O
Gynecol Endocrinol; 2008 Mar; 24(3):151-3. PubMed ID: 18335330
[TBL] [Abstract][Full Text] [Related]
27. Postmenopausal hyperandrogenism caused by a benign cystic teratoma: a case report.
Wu DH; McMurtrie DG; Hirsch SD; Johnston CM
J Reprod Med; 2008 Feb; 53(2):141-4. PubMed ID: 18357809
[TBL] [Abstract][Full Text] [Related]
28. Ovarian Leydig cell tumor in a post-menopausal patient with severe hyperandrogenism.
Souto SB; Baptista PV; Braga DC; Carvalho D
Arq Bras Endocrinol Metabol; 2014 Feb; 58(1):68-75. PubMed ID: 24728167
[TBL] [Abstract][Full Text] [Related]
29. Bilateral ovarian stromal hyperplasia concealing a nonhilar, pure stromal-Leydig cell tumor. A case report.
Oler A; Singh M; Ural SH
J Reprod Med; 1999 Jun; 44(6):563-6. PubMed ID: 10394554
[TBL] [Abstract][Full Text] [Related]
30. [Ovarian Leydig cell tumor].
Tönnies P; Mlynek-Kersjes ML; Gellén J; Watermann D
Zentralbl Gynakol; 1997; 119(5):241-5. PubMed ID: 9281260
[TBL] [Abstract][Full Text] [Related]
31. Diagnostic pitfalls in ovarian androgen-secreting (Leydig cell) tumours: case series.
Fanta M; Fischerová D; Indrielle-Kelly T; Koliba P; Zdeňková A; Burgetová A; Vrbíková J
J Obstet Gynaecol; 2019 Apr; 39(3):359-364. PubMed ID: 30428740
[TBL] [Abstract][Full Text] [Related]
32. Hilar cell tumor of the ovary: preoperative localization by selective retrograde venous sampling.
Aleem FA; Spenillo AR; Oberlander S; Surks MI
Obstet Gynecol; 1980 Jul; 56(1):99-102. PubMed ID: 6247678
[TBL] [Abstract][Full Text] [Related]
33. Leydig cell tumour and mature ovarian teratoma: rare androgen-secreting ovarian tumours in postmenopausal women.
Palha A; Cortez L; Tavares AP; Agapito A
BMJ Case Rep; 2016 Nov; 2016():. PubMed ID: 27803082
[TBL] [Abstract][Full Text] [Related]
34. Pure Leydig cell tumour (hilus cell) of the ovary: a rare cause of virilization after menopause.
Baiocchi G; Manci N; Angeletti G; Celleno R; Fratini D; Gilardi G
Gynecol Obstet Invest; 1997; 44(2):141-4. PubMed ID: 9286731
[TBL] [Abstract][Full Text] [Related]
35. Virilizing hilus (Leydig) cell tumor of the ovary: the challenge of an accurate preoperative diagnosis.
Raaf JH; Bajorunas DR; Smith DH; Woodruff J
Surgery; 1983 Dec; 94(6):951-4. PubMed ID: 6648810
[TBL] [Abstract][Full Text] [Related]
36. [The diagnosis of androgen producing tumours in women (author's transl)].
Hardt W; Sörensen R; Schnoy N; Gräf KJ; Moltz L; Schmidt-Gollwitzer M
Geburtshilfe Frauenheilkd; 1980 Apr; 40(4):373-80. PubMed ID: 7380237
[TBL] [Abstract][Full Text] [Related]
37. Bilateral Leydig cell tumour of the ovary: a rare cause of virilization in postmenopausal patient.
Sanz OA; Martinez PR; Guarch RT; Goñi MJ; Alcazar JL
Maturitas; 2007 Jun; 57(2):214-6. PubMed ID: 17289310
[TBL] [Abstract][Full Text] [Related]
38. Secondary amenorrhoea due to Leydig cell tumour.
Elbadrawy M; Davies N
J Obstet Gynaecol; 2005 Jul; 25(5):529-30. PubMed ID: 16183608
[No Abstract] [Full Text] [Related]
39. The Masquerading, Masculinizing Tumor: A Case Report and Review of the Literature.
LeVee A; Suppogu N; Walsh C; Sacks W; Simon J; Shufelt C
J Womens Health (Larchmt); 2021 Jul; 30(7):1047-1051. PubMed ID: 32991246
[TBL] [Abstract][Full Text] [Related]
40. Leydig cell tumor in the post-menopausal woman: case report and literature review.
Sherf S; Martinez D
Acta Biomed; 2016 Jan; 87(3):310-313. PubMed ID: 28112699
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
